QA: Concert Pharmaceuticals INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367920_2018_Concert_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001367920, Concert Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 205,734,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,165,000
3 remainder_Assets 3,837,000
4 LiabilitiesCurrent 6,445,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 8,859,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,553,929
9 ResearchAndDevelopmentExpense 30,260,164
10 remainder_Expenses 0
11 remainder_Revenues 246,459
12 remainder_NetIncome 34,580
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 211,736,000
1 Liabilities 15,304,000
2 Expenses 52,814,093
3 Revenues 246,459
4 StockholdersEquity 196,432,000
5 NetIncome -52,533,054
6 ComprehensiveNetIncome -52,533,054
7 BaseVar 140,067,566
8 EconomicCapitalRatiobeforeLimitedLiability 3.31
9 EconomicCapitalRatio 3.90

Edgar->Model Mapping

Feature Distribution

Change over Time